Mergers and Acquisitions

By integrating BioMimetics’ breakthrough biologics platform and pipeline into its extremities business, Wright Medical Group will hope to dominate the market, especially if the company’s Augment® bone graft gets the FDA PMA nod.

A spin-out from a Belgian University has been snapped up by Sorin, in a deal which looks like it’s intended to give the Italian Cardiovascular company a toe-hold in vagus stimulation therapies for heart failure patients.

Well well well. All the big players have renal denervation systems in development or already in the catalogue. Now, so does Boston Scientific with the year’s least surprising acquisition of Vessix Vascular.

Neomend reckons its PEG-based spray-on sealant has many applications. Presumably so does Bard, which has just announced the purchase of the California-based outfit.

Stryker’s Neuro Division bag is filling nicely with the newly announced acquisition of Surpass Medical, a company with interesting Neuro flow diverter technology in its portfolio.

St.Jude and AorTech’s disputes are developing into an interesting story as the two parties home in on what looks like an inevitable termination early next month. Or, in what may look like rather a long shot at the moment, it may end up as an acquisition.

Boston Scientific is to acquire Rhythmia Medical, Inc. as it seeks to build its position in cardiac rhythm management. Rhythmia is a developer of mapping and navigation systems for cardiac ablation techniques and expects to have products in market next year.

Edwards’ critical care portfolio expands to Include non-Invasive platform with the acquisition of Dutch monitoring company BMEYE.

Capsule endoscopy company Given Imaging Ltd. has acquired from The SmartPill Corporation, a U.S. based-company, the assets related to the SmartPill® GI Monitoring System for $6 million including earn-outs based on revenue between now and 2016.

Medtronic, Inc. and China Kanghui Holdings announced today that they have entered into a merger agreement whereby Medtronic will acquire Kanghui. The agreement calls for Medtronic to pay approximately $816 million in cash.

Boston Scientific Corporation is to acquire BridgePoint Medical, Inc., developer of a proprietary, catheter-based system to treat coronary chronic total occlusions.

ConvaTec says it has entered into a definitive agreement to acquire all of the capital stock of 180 Medical Holdings, Inc. for $321 million. 180 Medical is a leading U.S. provider of disposable, intermittent catheters and urologic medical supplies.

Tornier buying OrthoHelix will bring innovative Foot & Ankle technologies to Europe as well as high growth, line extension and gross margin to Tornier.

Presumably with its strong focus on peripheral vascular surgery, Vascular Solutions sees more potential than St.Jude does for this steerable guidewire catheter… enough to pay $3M for residual inventory and rights.

It looks like only the due diligence and PR teams are not on holiday this week as we see a flurry of announcements about M&A activity in medical devices, from 3D HD cameras to Therapeutic Supports to “Nutraceuticals”.

Cardiac telemedicine specialist CardioNet, Inc. has entered into a definitive merger agreement with cardioCORE Lab, Inc., a leading centralised cardiac testing laboratory. The move is seen as exploiting an adjacent market, while de-risking by broadening CardioNet’s business base.